Fresenius Medcare: 2020 adjusted net income up 10%
(CercleFinance.com) - Fresenius Medical Care, Fresenius's dialysis subsidiary, has posted a 10% increase in adjusted net profit to 1.
36 billion euros for 2020, with revenues up 2% to nearly 17.9 billion euros (+5% at constant exchange rates).
Based on these results, which have achieved the group's targets, the German group will propose to its general meeting to be held in May to increase its dividend for the 24th consecutive time, to 1.34 euro per share.
For 2021, Fresenius MedCare "expects revenue to grow at a low- to mid-single digit percentage rate and net income to decline at a high-teens to mid-twenties percentage rate".
Copyright (c) 2021 CercleFinance.com. All rights reserved.
36 billion euros for 2020, with revenues up 2% to nearly 17.9 billion euros (+5% at constant exchange rates).
Based on these results, which have achieved the group's targets, the German group will propose to its general meeting to be held in May to increase its dividend for the 24th consecutive time, to 1.34 euro per share.
For 2021, Fresenius MedCare "expects revenue to grow at a low- to mid-single digit percentage rate and net income to decline at a high-teens to mid-twenties percentage rate".
Copyright (c) 2021 CercleFinance.com. All rights reserved.